Dimensional Fund Advisors LP Fibrogen Inc Transaction History

Dimensional Fund Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$11.4 - $14.6 $5.78 Million - $7.41 Million	-507,244 Reduced 85.5%	86,025 $1.12 Million
Q2 2022 Aug 12, 2022	SELL	$7.94 - $12.96 $1.1 Million - $1.8 Million	-138,914 Reduced 18.97%	593,269 $6.27 Million
Q1 2022 May 13, 2022	BUY	$12.02 - $16.79 $5.91 Million - $8.26 Million	491,722 Added 204.49%	732,183 $8.8 Million
Q4 2021 Feb 09, 2022	BUY	$9.93 - $15.39 $280,304 - $434,428	28,228 Added 13.3%	240,461 $3.39 Million
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $633,593 - $1.66 Million	-62,239 Reduced 22.68%	212,233 $2.17 Million
Q2 2021 Aug 12, 2021	SELL	$18.57 - $35.68 $920,403 - $1.77 Million	-49,564 Reduced 15.3%	274,472 $7.31 Million
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $2 Million - $3.59 Million	-64,512 Reduced 16.6%	324,036 $11.2 Million
Q4 2020 Feb 25, 2021	BUY	$37.09 - $48.97 $14.4 Million - $19 Million	388,548 New	388,548 $14.4 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.